CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and financial results for the year ended December 31, 2020.
News
GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019
CARLSBAD, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on?Wednesday, November 6, 2019. Management will hold a confere… […]
News
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canacc… […]
News
GenMark Awarded BARDA Grant for the Development of ePlex? RP2 Panel
CARLSBAD, Calif., March 23, 2020 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has been awarded a grant from the Biomedical Advanced Re… […]
